Is the Market Poised for Some Gains Right Now? Our streak of bringing you winners continues Good day everyone, The markets gave back some of their gai...
FDA Approves Mycapssa (octreotide) Oral Somatostatin Analog for Acromegaly
Article Link: FDA Approves Mycapssa (octreotide) Oral Somatostatin Analog for Acromegaly NEEDHAM, Mass., June 26, 2020 (GLOBE NEWSWIRE) &...
(NASDAQ: CTXR) Hitting $1.30/Share in after market on Rumors of FDA Approval for Mino-Lok
CTXR and Mino-Lok Get Positive Feedback From the FDA, We have not had time to confirm this story. So we have included our most recent report here. Goo...
FDA Approves Fintepla (fenfluramine) for the Treatment of Seizures Associated with Dravet Syndrome
Article Link: FDA Approves Fintepla (fenfluramine) for the Treatment of Seizures Associated with Dravet Syndrome EMERYVILLE, Calif., June...
FDA Approves Merck’s Keytruda (pembrolizumab) for the Treatment of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) that is Not Curable by Surgery or Radiation
Article Link: FDA Approves Merck’s Keytruda (pembrolizumab) for the Treatment of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcino...
Karyopharm Announces FDA Approval of Xpovio (selinexor) for the Treatment of Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Article Link: Karyopharm Announces FDA Approval of Xpovio (selinexor) for the Treatment of Patients with Relapsed or Refractory Diffuse Large B-cell L...
Stay Tuned and be Prepared We Have a New NASDAQ Tech Report that will be Available Monday June 22nd, 2020 at Market Open
The NASDAQ Continues to Run The search for high growth opportunities Stay tuned and be prepared we have a new report that will be available Monday Jun...
FDA Approves New Dupixent (dupilumab) Pre-Filled Pen Designed to Support More Convenient Self-Administration
Article Link: FDA Approves New Dupixent (dupilumab) Pre-Filled Pen Designed to Support More Convenient Self-Administration CAMBRIDGE, Mas...
FDA Approves Gimoti (metoclopramide) Nasal Spray for Diabetic Gastroparesis
Article Link: FDA Approves Gimoti (metoclopramide) Nasal Spray for Diabetic Gastroparesis SOLANA BEACH, Calif., June 19, 2020 (GLOBE NEWS...
Ultragenyx and Kyowa Kirin Announce U.S. FDA Approval of Crysvita (burosumab) for the Treatment of Tumor-Induced Osteomalacia (TIO)
Article Link: Ultragenyx and Kyowa Kirin Announce U.S. FDA Approval of Crysvita (burosumab) for the Treatment of Tumor-Induced Osteomalacia (TIO) ...